Unavailability of Visudyne 15 mg (powder for solution for infusion) : recommendations for (hospital) pharmacists and physicians-specialists
August 17, 2021
The medicinal product Visudyne 15 mg, used in ophthalmology, has been unavailable in Belgium since 30 May 2020. The FAMHP is therefore making recommendations.
Source: FAMHP
The medicinal product Visudyne 15 mg, used in ophthalmology, has been unavailable in Belgium since 30 May 2020. The FAMHP is therefore making recommendations.
Since 30 May 2020 Visudyne has been unavailable. Since 1 June 2021 the marketing authorisation holder Cheplapharm has reported a temporary halt to commercialisation. The expected end date is 1 February 2022.
Experts from the FAMHP Unavailability Task Force provide the following recommendations for (hospital) pharmacists and physicians-specialists.